Lung Screening to Radiogenomics: Future Directions in CT-Based Precision Diagnostics for Non-Small Cell Lung Cancer (NSCLC)

Description

This future-focused session will introduce a flexible and comprehensive lung screening solution and explore how emerging radiogenomics approaches may extend the role of CT in diagnostics beyond detection towards non-invasive characterisation of tumour biology in non-small cell lung cancer (NSCLC). Drawing on collaborative research with NHS Greater Glasgow & Clyde and the University of Glasgow, the presentation will outline ongoing work to investigate whether routine CT imaging can help predict tumour mutation status and support more rapid diagnostic assessment. 

The session will describe the technological direction of this work, its potential clinical relevance, and the possible value it may offer to patients, clinicians, and healthcare providers. It will also consider how advances in CT-based image analysis may contribute to future precision diagnostic pathways, including improved stratification and more informed treatment planning. 

• Describe the key components of a flexible and comprehensive lung screening solution
• Summarise the aims and direction of the radiogenomics research being undertaken with NHS Greater Glasgow & Clyde and the University of Glasgow
• Recognise the potential role of CT imaging in supporting non-invasive assessment of NSCLC tumour mutation status 
• Explain how emerging radiogenomics technologies may contribute to future patient stratification and diagnostic pathways in lung cancer 

This session has been CPD accredited by The College of Radiographers.

This session will be hosted by Canon Medical Systems UK during UKIO 2026.